Prevent brand name drug companies from using patent settlements to block cheaper generic versions from entering the market.
One policy goal, tracked across every bill that has carried it.
What’s happening with Ensuring Timely Access to Generics Act of 2025?
The Ensuring Timely Access to Generics Act of 2025, known as S. 3014, has been in the Senate Committee on Health, Education, Labor, and Pensions since October 15, 2025. The committee members must now decide whether to hold a vote on the bill, but most legislation fails because committees do not take action. This bill has seen no movement since October 15, 2025, and historical data shows that the vast majority of bills never receive a committee vote.
Updated July 9, 2026 · Generated by AI. Always verify with official sources.
Where it stands
Now carried by Ensuring Timely Access to Generics Act of 2025 (S. 3014 (119th)) →
Legislative Progress
How we got here
Every bill that has carried this goal, oldest first.
Died with Congress · Jan 3, 2025
Died when the 118th Congress ended without final passage. Bills must be reintroduced under a new number to be revived.
Reintroduced · Jan 3, 2025
Reintroduced from S. 1067 (118th), which died when its Congress ended.
S. 1067 (118th) →
Vehicles
Who’s behind it
Jeanne Shaheen (D-NH)Wrote and sponsored the current bill.